GPC2 promotes prostate cancer progression via MDK-mediated activation of PI3K/AKT signaling pathway.
Ontology highlight
ABSTRACT: Prostate cancer is a major medical problem for men worldwide. Advanced prostate cancer is currently incurable. Recently, much attention was paid to the role of GPC2 in the field of oncology. Nevertheless, there have been no investigations of GPC2 and its regulatory mechanism in prostate cancer. Here, we revealed a novel action of GPC2 and a tumor promoting mechanism in prostate cancer. GPC2 was upregulated in prostate cancer tissues and cell lines. Higher expression of GPC2 was correlated with higher Gleason score, lymphatic metastasis, and worse overall survival in prostate cancer patients. Decreased expression of GPC2 inhibited cell proliferation, migration, and invasion in prostate cancer, whereas GPC2 overexpression promoted these properties. Mechanistically, GPC2 promoted the activati
SUBMITTER: Chen S
PROVIDER: S-EPMC11252201 | biostudies-literature | 2024 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA